GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vifor Pharma AG (XSWX:VIFN) » Definitions » YoY Rev. per Sh. Growth

Vifor Pharma AG (XSWX:VIFN) YoY Rev. per Sh. Growth : 1.14% (As of Dec. 2021)


View and export this data going back to 2003. Start your Free Trial

What is Vifor Pharma AG YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. Vifor Pharma AG's YoY Rev. per Sh. Growth for the quarter that ended in Dec. 2021 was 1.14%.

Vifor Pharma AG's Revenue per Share for the six months ended in Dec. 2021 was CHF14.87.


Vifor Pharma AG YoY Rev. per Sh. Growth Historical Data

The historical data trend for Vifor Pharma AG's YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vifor Pharma AG YoY Rev. per Sh. Growth Chart

Vifor Pharma AG Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
YoY Rev. per Sh. Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.61 22.49 8.80 4.54 1.26

Vifor Pharma AG Semi-Annual Data
Jun12 Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21
YoY Rev. per Sh. Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.62 -7.47 17.54 1.79 1.14

Vifor Pharma AG YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

Vifor Pharma AG's YoY Rev. per Sh. Growth for the fiscal year that ended in Dec. 2021 is calculated as:

YoY Rev. per Sh. Growth (A: Dec. 2021 )
=(Revenue per Share (A: Dec. 2021 )-Revenue per Share (A: Dec. 2020 ))/ | Revenue per Share (A: Dec. 2020 ) |
=(28.069-27.721)/ | 27.721 |
=1.26 %

Vifor Pharma AG's YoY Rev. per Sh. Growth for the quarter that ended in Dec. 2021 is calculated as:

YoY Rev. per Sh. Growth (Q: Dec. 2021 )
=(Revenue per Share (Q: Dec. 2021 )-Revenue per Share (Q: Dec. 2020 )) / | Revenue per Share (Q: Dec. 2020 )) |
=(14.869-14.701)/ | 14.701 |
=1.14 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vifor Pharma AG YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of Vifor Pharma AG's YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Vifor Pharma AG (XSWX:VIFN) Business Description

Traded in Other Exchanges
N/A
Address
Rechenstrasse 37, Saint Gallen, CHE, 9014
Vifor Pharma AG is a specialty drug manufacturing and licensing company. It researches, develops, and produces its pharmaceutical products and markets and distributes them worldwide. Most of its sales are generated in the USA, with Europe also a strong contributor. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Vifor Pharma AG (XSWX:VIFN) Headlines

No Headlines